As of Jul 27
| -0.08 / -1.03%|
The 3 analysts offering 12-month price forecasts for Juniper Pharmaceuticals Inc have a median target of 15.00, with a high estimate of 20.00 and a low estimate of 15.00. The median estimate represents a +95.31% increase from the last price of 7.68.
The current consensus among 3 polled investment analysts is to Buy stock in Juniper Pharmaceuticals Inc. This rating has held steady since July, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.